Vonoprazan Fumarate

CAS 1260141-27-2 23 FDA-DMF suppliersSmall Molecule

Overview

Vonoprazan Fumarate is a potassium-competitive acid blocker (PCAB) used to treat conditions such as gastroesophageal reflux disease (GERD). It provides an alternative mechanism of action to proton pump inhibitors by inhibiting the gastric H+, K+-ATPase enzyme.

API suppliers (7)

Suppliers of Vonoprazan Fumarate backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • SHANDONG XINHUA PHARMACEUTICAL CO LTDChina2 active DMF
  • Zhejiang Hisun Pharmaceutical Co., Ltd.China2 active DMF
  • MAHIMA LIFE SCIENCES PRIVATE LTD2 active DMF
  • HIKAL LTD1 active DMF
  • HIKAL LTD1 active DMF
  • HIKAL LTD1 active DMF
  • BEIJING MESOCHEM TECHNOLOGY CO LTD1 active DMF

Therapeutic areas

Gastroenterology

Related APIs

Pantoprazole
53 suppliers
Lansoprazole
35 suppliers
Mesalamine
30 suppliers
Famotidine
25 suppliers
Budesonide
24 suppliers
Rabeprazole Sodium
20 suppliers
Octreotide Acetate
20 suppliers
Sucralfate
19 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo